Uni-Bio Science Group (HKSE:00690) Cash-to-Debt : 2.30 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Uni-Bio Science Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Uni-Bio Science Group's cash to debt ratio for the quarter that ended in Dec. 2023 was 2.30.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Uni-Bio Science Group could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Uni-Bio Science Group's Cash-to-Debt or its related term are showing as below:

HKSE:00690' s Cash-to-Debt Range Over the Past 10 Years
Min: 2.3 Med: 17.19 Max: No Debt
Current: 2.3

During the past 13 years, Uni-Bio Science Group's highest Cash to Debt Ratio was No Debt. The lowest was 2.30. And the median was 17.19.

HKSE:00690's Cash-to-Debt is ranked worse than
64.74% of 1506 companies
in the Biotechnology industry
Industry Median: 6.11 vs HKSE:00690: 2.30

Uni-Bio Science Group Cash-to-Debt Historical Data

The historical data trend for Uni-Bio Science Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Uni-Bio Science Group Cash-to-Debt Chart

Uni-Bio Science Group Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

78.06

19.45

14.94

4.33

2.30

Uni-Bio Science Group Semi-Annual Data
	Sep14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash-to-Debt	Get a 7-Day Free Trial															10.13	4.33	4.75	2.30	N/A

Competitive Comparison of Uni-Bio Science Group's Cash-to-Debt

For the Biotechnology subindustry, Uni-Bio Science Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Uni-Bio Science Group's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Uni-Bio Science Group's Cash-to-Debt falls into.

Uni-Bio Science Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Uni-Bio Science Group's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	129.236	/	(18.697	+	37.602)
	=	2.30

Uni-Bio Science Group's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	129.236	/	(18.697	+	37.602)
	=	2.30

Uni-Bio Science Group (HKSE:00690) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Uni-Bio Science Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Uni-Bio Science Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Uni-Bio Science Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Uni-Bio Science Group Ltd (HKSE:00690) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG

Website

https://www.uni-bioscience.com

Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.

Executives

Automatic Result Limited
Mjkpc Holdings Limited
Leung Kingsley
Century Ally Ventures Limited	2201 Interest of corporation controlled by you
Fih (bvi) Limited	2201 Interest of corporation controlled by you
Petite Arbre Limited	2201 Interest of corporation controlled by you
Tmf (cayman) Ltd.	2301 Trustee
Xjg Capital Management Limited	2201 Interest of corporation controlled by you
Yau Kwok Wing Tony	2201 Interest of corporation controlled by you
Lau Kan Sum	2307 Founder of a discretionary trust who can infl
Credit Suisse Trust Limited	2301 Trustee
Mjkpc Holdings Limited	2201 Interest of corporation controlled by you

Uni-Bio Science Group Headlines

No Headlines